2024 University of Illinois Cancer Center
Winter CME Series

January 24, 2024 – GU, GI, and Thoracic Oncology

January 31, 2024 – Women’s Cancers – Year in Review

February 7, 2024 – Hematologic Malignancies – Update from ASH

THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TUESDAY BEFORE EACH OF THE SESSIONS.

YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.

Venue SIX10
610 South Michigan Avenue
Chicago, Illinois 60605
312-322-1725

Proudly Hosted by New York Oncology Hematology, PC

Organized By:

Hosted By:

Conference Information

The sessions were recorded and will be posted online for on-demand access within 60-90 days following the live events.

THE DETAILS FOR EACH SESSION
ARE AVAILABLE BELOW BY SESSION DATE.

REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00

Cancellation Policy:

Cancellations and refunds will be processed based on the following:

Up to 30 days prior to the conference = 100%

29 - 15 days prior to the conference = 50%

14-7 days prior to the conference = 25%

6-0 days prior to the conference = 0%

If you would like to request a refund, please email [email protected]

Registration

If you would like to be added to our mailing list to be notified about future programs and activities, please complete the form below:

DETAILS FOR SESSION 1: JANUARY 24, 2024 – GU, GI, AND THORACIC ONCOLOGY

Educational Goal

This conference aims to educate practitioners and update their knowledge of advances in diagnosing and managing GU, GI, and Thoracic Cancers.

Target Audience

The target audience for this conference is medical oncologists, hematologists, pathologists, oncology nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers interested in the care of patients with cancer.

learning Objectives

After participating in these activities, learners will be better able to:

Participants will be able to evaluate the efficacy and safety of using PARP inhibitors in managing HRR-mutated metastatic prostate cancer, including potential side effects and monitoring parameters.
Participants will be able to review the latest guidelines and recommendations for peri-operative therapy in localized rectal cancer.
Participants will identify the role and significance of biomarkers in early and advanced-stage non-small
cell lung cancer

Agenda

Day 1 – Wednesday, January 24, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
2:50 – 3:35pm – The Evolving Landscape of Peri-operative Therapy for Localized Rectal Cancer: What Clinicians Need to Know
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Navigating Neoadjuvant Options: Current Updates in the Perioperative Treatment for Early-Stage Lung Cancer
5:20 – 6:05pm – Precision Oncology: Leveraging Biomarkers for First-Line Treatment in NSCLC
6:05 – 7:00pm – Exhibits, Ancillary Events

Session 1 Materials

• GUIDEBOOK
• SPONSORS AND EXHIBITORS
• PRODUCT THEATER — SPONSORED BY REGENERON

Series Course Chair

VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL

Co-Chair

Ryan Nguyen, DO
Assistant Professor of Clinical Medicine
Director, Precision Oncology Tumor Board
University of Illinois Cancer Center
Chicago, IL

Faculty

Karine Tawagi, MD
Assistant Professor of Medicine, Division of Hematology/Oncology, Genitourinary Oncology Program Director, Division of Hematology/Oncology
University of Illinois
Chicago, IL

Shikha Jain MD, FACP
Tenured Associate Professor of Medicine
GI Oncology Integrated Practice Unit (IPU) Lead
Director of Communication Strategies in Medicine
Associate Director of Oncology Communication & Digital Innovation
University of Illinois Cancer Center
Chicago, IL

Frank Weinberg, MD, PhD
University of Illinois Cancer Center
Chicago, IL

DETAILS FOR SESSION 2: JANUARY 31, 2024 – WOMEN’S CANCERS – YEAR IN REVIEW

Educational Goal

This conference aims to educate practitioners and update their knowledge of advances in diagnosing and managing women-related cancers.

Target Audience

The target audience for this conference is medical oncologists, hematologists, pathologists, oncology
nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners,
allied health professionals, and other providers interested in the care of patients with cancer.

learning Objectives

After participating in these activities, learners will be better able to:

Discuss current and future roles of newly approved targeted therapies in all breast cancer subtypes
Understand the side effects of practice-changing novel therapies and their integration into community practice
Discuss emerging strategies for patients with platinum-resistant ovarian cancer

Agenda

Day 2 – Wednesday, January 31, 2024
1:00 - 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Recent Updates in Early-Stage Breast Cancer
2:50 – 3:35pm – Metastatic Breast Cancer Overview: Come Learn all the new Study Acronyms!
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Update in Genetics for the Oncologist
5:20 – 6:05pm – Incorporating Immunotherapy and other New Agents in Endometrial and Cervical Cancers
6:05 – 7:00pm – Exhibits, Ancillary Events

VIEW AGENDA

Session 2 Materials

• GUIDEBOOK
• SPONSORS AND EXHIBITORS
• PRODUCT THEATER — SPONSORED BY ASTRAZENECA
• VIEW AGENDA

Series Course Chair

VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL

Co-Chair

Abiola Ibraheem, MD
Title: Assistant Professor
Division of Hematology/Oncology
Department of Medicine
Center for Global Health
University of Illinois Cancer Center
Chicago, IL

Faculty

Jocelyn Ray, MD, PhD
University of Illinois Cancer Center
Chicago, IL

Kent Hoskins, MD
Eileen Lindsey Heidrick Professor in Oncology and Professor of Medicine
Department of Medicine, Division of Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL

DETAILS FOR SESSION 3: FEBRUARY 7, 2024 – HEMATOLOGIC MALIGNANCIES – UPDATE FROM ASH

Educational Goal

This conference aims to educate practitioners and update their knowledge of advances in diagnosing and managing Hematologic Malignancies.

Target Audience

learning Objectives

After participating in these activities, learners will be better able to:

Discuss the optimal strategies for the use of CAR T Cell and bispecific T-cell engagers in Diffuse Large B Cell Lymphoma
Explain how to optimize treatment selection in Multiple Myeloma, including the use of bispecific T- Cell engagers
Identify novel treatment approaches in Acute Lymphoblastic and Acute Myeloid Leukemia

Agenda

Day 3 – Wednesday, February 7, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm - Introduction
2:05 – 2:50pm – How to best incorporate CAR T and new targeted immunotherapy in DLBCL
2:50 – 3:35pm – Management of newly diagnosed and relapsed Multiple Myeloma in 2024
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Emerging induction and consolidation regimens in Acute Lymphoblastic Leukemia
5:20 – 6:05pm – Latest advancements in targeted therapy in Acute Myeloid Leukemia
6:05 – 7:00pm – Exhibits, Ancillary Events

Session 3 Materials

• ONLINE ATTENDEES - PLEASE SIGN IN
• PRE-TEST - MUST BE COMPLETED
• AGENDA
• GUIDEBOOK
• SUPPORTER ACKNOWLEDGEMENT
• PRODUCT THEATER SPONSORED BY SANOFI

Series Course Chair

VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL

Co-Chair

Matias E. Sanchez, MD
Assistant Professor Medicine
Division Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL

Faculty

Carlos Galvez, MD
University of Illinois Cancer Center
Chicago, IL

John Quigley, MD
University of Illinois Cancer Center
Chicago, IL

Noah Birch, MD
University of Illinois Cancer Center
Chicago, IL

Support Opportunities

Click HERE for the sponsorship opportunity details.

If you are interested in a Product Theater or Onsite Meeting Space, please email
[email protected] to discuss availability before you complete the application.

To complete the application, please go to: https://cmersvp.com/exhibit-processing-form/

For custom sponsorship packages, please get in touch with Nicole @ 815-861-9069 /
[email protected]

Click HERE to view the Agenda

Exhibitor Information - Logistics - Click HERE

UICMEW 4th Floor Diagram - Click HERE

Accreditation

This activity is jointly provided by Global Education Group and myMedEd.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and myMedEd, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation
Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].

Instructions for Obtaining Credit
In order to receive credit, participants must attend the activity in its entirety. Participants must also score at least a
70% on the post-test and submit it, along with the credit application and evaluation form. Statements of credit will
be emailed within 4 to 6 weeks following the program.

System Requirement

PC
1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla
Firefox (v65.0 & above), and Edge (v42.0 & above)

MAC
1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above),
Apple Safari (v12.0 & above), and Mozilla Firefox
(v65.0 & above)

Fee Information & Refund/Cancellation Policy
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00

Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%

If you would like to request a refund, please email [email protected]

Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The planners and managers at Global Education Group and MyMedEd have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and myMedEd do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act
Event staff will gladly assist you with any special needs (I.e., physical, dietary, etc.). Please contact myMedEd, inc. before the live event at (800) 973-0665 x2.

Organized By:

Educational Partners

Hosted By:

2024 University of Illinois Cancer Center
Winter CME Series

January 24, 2024 – GU, GI, and Thoracic Oncology

January 31, 2024 – Women’s Cancers – Year in Review

February 7, 2024 – Hematologic Malignancies – Update from ASH

THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TUESDAY BEFORE EACH OF THE SESSIONS.

YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.

Venue SIX10
610 South Michigan Avenue
Chicago, Illinois 60605
312-322-1725

Organized By:

Hosted By:

Conference Information

Registration

Educational Goal

Target Audience

learning Objectives

Agenda

Session 1 Materials

Series Course Chair

Co-Chair

Faculty

Educational Goal

Target Audience

learning Objectives

Agenda

Session 2 Materials

Series Course Chair

Co-Chair

Faculty

Educational Goal

Target Audience

learning Objectives

Agenda

Session 3 Materials

Series Course Chair

Co-Chair

Faculty

Support Opportunities

HOW TO GET TO VENUE SIX10

Parking and Public Transit Information

Accreditation

2024 University of Illinois Cancer CenterWinter CME Series

January 24, 2024 – GU, GI, and Thoracic Oncology

January 31, 2024 – Women’s Cancers – Year in Review

February 7, 2024 – Hematologic Malignancies – Update from ASH

THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TUESDAY BEFORE EACH OF THE SESSIONS. YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.

Venue SIX10 610 South Michigan Avenue Chicago, Illinois 60605 312-322-1725

Organized By:

Hosted By:

Conference Information

Registration

Educational Goal

Target Audience

learning Objectives

Agenda

Session 1 Materials

Series Course Chair

Co-Chair

Faculty

2024 University of Illinois Cancer Center
Winter CME Series

THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT TUESDAY BEFORE EACH OF THE SESSIONS.

YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.

Venue SIX10
610 South Michigan Avenue
Chicago, Illinois 60605
312-322-1725